STOCK TITAN

Innovation Beverage restates 2024 loss to $4.7M

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Innovation Beverage Group Ltd (IBG) announced that its Board, following recommendations from management and the Audit Committee and consultations with its current and former auditors, determined that the company’s audited consolidated financial statements for the year ended December 31, 2024 should no longer be relied upon and must be restated. These errors affect multiple balance sheet and income statement line items, though the company states its cash position is unchanged.

The restatement reduces 2024 total assets and stockholders’ equity and increases total liabilities, accumulated deficit, net loss, operating expenses and impairment expense. Basic and diluted net loss per share also increased in absolute terms after giving effect to prior reverse stock splits. Management identified material weaknesses in internal control over financial reporting, including insufficient written policies, limited segregation of duties, and inadequate controls over related-party transactions, and plans to detail remediation efforts in its 2025 Form 20-F. The company has notified Nasdaq of these matters and is working regarding its continued listing obligations.

Positive

  • None.

Negative

  • 2024 net loss increased from $2,571,333 to $4,700,315 after restatement, significantly worsening reported profitability.
  • Total stockholders’ equity fell from $2,619,109 to $415,865, a reduction of $2,203,244, indicating a much weaker balance sheet.
  • Management disclosed material weaknesses in internal control over financial reporting, including policies, segregation of duties and related-party transaction controls.
  • The company notified Nasdaq and is working on continued listing obligations, highlighting potential listing-compliance risk.

Filing Explained

The restatement cuts December 31, 2024 equity to $415,865 and raises liabilities to $3,354,148; corrected statements are still pending.

Form 6-K is an interim report for a foreign private issuer; the company says its Board determined on September 15, 2026 that the 2024 financial statements can no longer be relied upon and must be restated. The corrected statements have not yet been filed.

At December 31, 2024, reported total assets were revised from $4,955,373 to $3,770,013, liabilities from $2,336,264 to $3,354,148, and stockholders’ equity from $2,619,109 to $415,865.

For 2024, net loss was revised from $2,571,333 to $4,700,315, while total operating expenses rose from $5,428,954 to $7,289,564 and impairment expense from $612,072 to $1,861,833. Aggregate cash flows did not change, although the presentation and classification of some cash-flow amounts did.

Basic and diluted net loss per share changed from ($7.74) to ($14.08) after retroactive adjustment for a cumulative 1-for-25 reverse stock split; that split reduces the share count and proportionally raises the per-share price without itself changing company value.

The stated resolution point is the company’s 2025 Form 20-F, which is expected to include the restated 2024 comparative statements and more detail on remediation; the filing also says additional adjustments could be identified before submission.

Total assets (Dec. 31, 2024) before vs. after restatement $4,955,373 vs. $3,770,013 Balance sheet as of December 31, 2024; assets decreased by $1,185,360 after restatement
Total liabilities (Dec. 31, 2024) before vs. after restatement $2,336,264 vs. $3,354,148 Balance sheet as of December 31, 2024; liabilities increased by $1,017,884
Stockholders’ equity (Dec. 31, 2024) before vs. after restatement $2,619,109 vs. $415,865 Balance sheet as of December 31, 2024; equity decreased by $2,203,244
Accumulated deficit (Dec. 31, 2024) before vs. after restatement $8,795,290 vs. $11,132,893 Balance sheet as of December 31, 2024; accumulated deficit increased by $2,337,603
Net loss 2024 before vs. after restatement $2,571,333 vs. $4,700,315 Year ended December 31, 2024; net loss increased by $2,128,982
Revenue 2024 before vs. after restatement $2,931,243 vs. $2,922,241 Year ended December 31, 2024; small downward adjustment to revenue
Total operating expenses 2024 before vs. after restatement $5,428,954 vs. $7,289,564 Year ended December 31, 2024; operating expenses increased after restatement
Basic and diluted net loss per share 2024 ($7.74) vs. ($14.08) Year ended December 31, 2024; adjusted for cumulative 1-for-25 reverse stock split
material weaknesses financial
"management has identified the following material weaknesses in the Company’s internal control"
Material weaknesses are significant flaws in a company’s systems for ensuring its financial reports are accurate and reliable. Like a broken lock on a safe, they increase the chance that financial statements contain big errors or omissions, which can mislead investors about performance and risk; discovering one often raises questions about management oversight, may lead to restated results, and can affect investor confidence and a company’s valuation.
internal control over financial reporting financial
"material weaknesses in the Company’s internal control over financial reporting"
Internal control over financial reporting is a company’s system of procedures and checks designed to make sure its financial statements are accurate and complete, like a set of guardrails and verification steps that catch mistakes or fraud before numbers are published. Investors care because strong controls make reported results more trustworthy, lower the risk of surprise restatements or regulatory problems, and give greater confidence when valuing the company or comparing it to peers.
accumulated deficit financial
"Accumulated deficit increased from $8,795,290 to $11,132,893"
Accumulated deficit is the running total of a company’s past net losses minus any profits, showing how much the business has eaten into its own funds over time—think of it like a bank account that’s been overdrawn by repeated shortfalls. It matters to investors because a large accumulated deficit reduces the cushion that protects owners and creditors, can limit dividends or borrowing, and signals how much funding the company may need to reach profitability.
reverse stock split financial
"amounts retroactively adjusted for the cumulative 1-for-25 reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
Nasdaq listing requirements regulatory
"ability to maintain compliance with Nasdaq listing requirements"
NASDAQ listing requirements are the financial, governance and disclosure rules a company must meet to have its shares traded on the NASDAQ stock exchange. Think of them as the standards a business must pass to join an exclusive marketplace — they affect whether a stock can be bought easily, how much public information the company must provide, and how investors judge its credibility and risk. Meeting these rules can boost liquidity and investor confidence.
forward-looking statements regulatory
"contains forward-looking statements within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did IBG disclose about its 2024 financial statements in this Form 6-K?

IBG’s Board determined that the audited 2024 financial statements should no longer be relied upon due to errors and must be restated. The company will include restated 2024 numbers as comparative figures in its Form 20-F for the year ended December 31, 2025.

How did the restatement affect Innovation Beverage Group (IBG)’s 2024 net loss?

The restatement increased IBG’s 2024 net loss from $2,571,333 to $4,700,315, an increase of $2,128,982. Basic and diluted net loss per share rose in absolute terms from ($7.74) to ($14.08), adjusted for the cumulative 1-for-25 reverse stock split.

How were IBG’s assets, liabilities, and equity changed by the restatement?

As of December 31, 2024, total assets decreased from $4,955,373 to $3,770,013, total liabilities increased from $2,336,264 to $3,354,148, and stockholders’ equity decreased from $2,619,109 to $415,865. Accumulated deficit increased from $8,795,290 to $11,132,893.

Did the IBG restatement affect the company’s cash position or cash flows?

IBG stated it does not expect any impact on its cash position. The restatement did not change cash flows in the aggregate but did change the classification and presentation of certain operating, investing, financing and foreign-currency amounts in the cash flow statement.

What internal control issues did Innovation Beverage Group (IBG) identify?

Management identified material weaknesses including insufficient written accounting and reporting policies, limited segregation of duties due to company size and nature, and a lack of formal policies and adequate controls for approval, identification and reporting of related-party transactions.

How does this restatement affect IBG’s Nasdaq listing status?

IBG reported that it has notified Nasdaq about the restatement and related matters and is working with Nasdaq regarding its continued listing obligations. The company also highlighted the risk of potential impact on compliance with Nasdaq listing requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16

OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2026

Commission file number: 001-42278

 

INNOVATION BEVERAGE GROUP LIMITED

(Translation of registrant’s name into English)

 

29 Anvil Road

Seven Hills, New South Wales, Australia, 2147

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Non-Reliance on Previously Issued Financial Statements

 

On September 15, 2026, the Board of Directors (the “Board”) of Innovation Beverage Group Limited (the “Company”), upon the recommendation of the Audit Committee of the Board (the “Audit Committee”) and management, and after consultation with both M&K CPAS, PLLC, the Company’s current independent registered public accounting firm (the “Auditor”) engaged October 15, 2025, and Astra Audit & Advisory LLC (“Astra”), the Company’s previous independent registered public accounting firm between December 12, 2024 and July 23, 2025, determined that the Company’s previously issued financial statements for the fiscal year ended December 31, 2024 (the “Affected Financial Statements”) should no longer be relied upon due to errors identified therein, and that a restatement of the Affected Financial Statements is required.

 

The Affected Financial Statements include the Company’s audited consolidated financial statements as of and for the fiscal year ended December 31, 2024, included in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on May 15, 2025. Accordingly, investors should no longer rely upon the Affected Financial Statements, or any earnings releases, investor presentations, or other communications relating to, or based upon, such financial statements.

 

Nature of Errors

 

These errors primarily involved the following five correction areas:

 

1.Intangible Assets and Accumulated Deficit (IP Rights). The Company corrected the timing of recognition of intellectual property (“IP”) rights acquired in August 2019 that had previously been recognized based on the subsequent share issuance. The correction reflects the IP asset and related historical amortization in the appropriate periods, increased intangible assets, net by $35,496 as of December 31, 2024, and included an adjustment to beginning accumulated deficit for historical amortization of $115,418 attributable to periods before 2024.

 

2.Asset Write-offs and Impairment. The Company corrected the accounting for the Rockland distribution agreement and the Wired for Wine liquor license and wrote off a loan receivable and accrued interest receivable due from a related party. As restated, impairment expense for the year ended December 31, 2024 was $1,861,833, compared with loss on asset write-off of $612,072 previously reported.

 

3.Unrecorded Equity Commitments. Management identified an aggregate of $1,225,427 of contractual obligations established in or before 2024 to issue ordinary shares that had not been recorded in the appropriate periods. These obligations included the Chief Executive Officer’s IPO bonus, board-approved staff and director allocations, a 2021 agreement with Tradigital, and the 2019 IP asset acquisition. The corrections resulted in adjustments to salaries and wages, other liabilities, ordinary shares and accumulated deficit.

 

4.Debt Issuances with Equity Components. Certain debt issuances included an equity component that had previously been recognized as an expense. The Company determined that the proceeds should instead be allocated between debt and equity components on a relative fair value basis, reducing previously recognized expense and adjusting the carrying amount of related debt and ordinary shares.

 

5.Other Corrections and Reclassifications. The restatement also includes corrections and reclassifications affecting certain prepaid expenses, right-of-use (“ROU”) assets and lease balances, equipment, accounts payable and accrued expenses, revenue and operating expense classifications, and foreign currency translation.

 

These errors affect various financial statement line items, including assets, liabilities, equity, and the statements of operations and comprehensive loss for the affected periods. The Company does not expect the restatement to have any impact on its cash position. The Company expects to include the restated fiscal year 2024 financial statements as comparative-period financial statements in its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, which has not yet been filed.

 

 

 

In connection with the restatement, management has identified the following material weaknesses in the Company’s internal control over financial reporting: (i) there are insufficient written policies and procedures to ensure the correct application of accounting and financial reporting with respect to the current requirements of U.S. GAAP and SEC disclosure requirements; (ii) due to the Company’s size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible; however, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals; and (iii) there are no formal policies or written procedures for the approval, identification and reporting of related-party transactions, and the Company’s controls are not adequate to ensure that all material transactions and developments with related parties will be properly identified, approved and reported. These material weaknesses contributed to the errors that required the restatement described above. The Company expects to describe these material weaknesses and its remediation efforts in more detail in its Annual Report on Form 20-F for the fiscal year ended December 31, 2025.

 

The Company has notified The Nasdaq Stock Market LLC of the matters described herein and is working with Nasdaq regarding its continued listing obligations. The decision to restate the financial statements was made by the Board upon the recommendation of management and the Audit Committee.

 

Summary of Restatement Impact

 

Balance Sheet (December 31, 2024). Total assets decreased from $4,955,373 as previously reported to $3,770,013 as restated, a decrease of $1,185,360. Total liabilities increased from $2,336,264 to $3,354,148, an increase of $1,017,884. Total stockholders’ equity decreased from $2,619,109 to $415,865, a decrease of $2,203,244. Accumulated deficit increased from $8,795,290 to $11,132,893, an increase of $2,337,603.

 

Income Statement (Year Ended December 31, 2024). Net loss increased from $2,571,333 to $4,700,315, an increase of $2,128,982. Revenue was adjusted from $2,931,243 to $2,922,241. Total operating expenses increased from $5,428,954 to $7,289,564, and impairment expense increased from $612,072 to $1,861,833.

 

Earnings Per Share. Basic and diluted net loss per share increased in absolute terms from ($7.74) to ($14.08), with the per-share amounts retroactively adjusted for the cumulative 1-for-25 reverse stock split (consisting of 1-for-5 reverse stock splits effected on September 26, 2025 and January 30, 2026).

 

Cash Flows. The restatement did not change the cash flows in the aggregate; however, it changed the classification and presentation of certain operating, investing, financing and foreign-currency amounts.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Report on Form 6-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, without limitation, statements regarding the Company’s intention to include the restated 2024 financial statements in its Annual Report on Form 20-F for the year ended December 31, 2025, the expected timing of that filing, the anticipated reporting of material weaknesses in internal control over financial reporting, and the Company’s remediation efforts. These statements involve known and unknown risks, uncertainties, and other factors that may cause the Company’s actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the Company’s ability to file its Annual Report on Form 20-F within the anticipated timeframe, the potential identification of additional adjustments prior to filing, the potential impact of the restatement on the Company’s business, financial condition, and results of operations, and the Company’s ability to maintain compliance with Nasdaq listing requirements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Innovation Beverage Group Limited
     
Date: September 16, 2026 By: /s/ Sahil Beri
    Name: Sahil Beri
    Title: Chief Executive Officer

 

 

Keep reading